MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
about
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.Misuse of Novel Synthetic Opioids: A Deadly New Trend.An Expanding World of Novel Psychoactive Substances: Opioids.Test purchase, synthesis, and characterization of 2-methoxydiphenidine (MXP) and differentiation from its meta- and para-substituted isomers.Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine.Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project.Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project.Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes.Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class.Adverse events related to the new psychoactive substance 3-fluorophenmetrazine - results from the Swedish STRIDA project.New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs.Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework.Novel psychoactive substances of interest for psychiatry.Updating the list of known opioids through identification and characterization of the new opioid derivative 3,4-dichloro-N-(2-(diethylamino)cyclohexyl)-N-methylbenzamide (U-49900).Non-targeted screening for novel psychoactive substances among agitated emergency department patients.Oral fluid drug analysis in the age of new psychoactive substances.Intoxications involving acrylfentanyl and other novel designer fentanyls - results from the Swedish STRIDA project.Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project.Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project.Phencyclidine analog use in Sweden--intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project.Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45.Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC-MS-MS and its Identification in a Drug-Related Death.Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45.Identification of Unique Metabolites of the Designer Opioid Furanyl Fentanyl.When good times go bad: managing 'legal high' complications in the emergency department.Identification and physicochemical characterization of 4-fluorobutyrfentanyl (1-((4-fluorophenyl)(1-phenethylpiperidin-4-yl)amino)butan-1-one, 4-FBF) in seized materials and post-mortem biological samples.Adulterant or contaminant in MT-45, or coingestion?Investigation of drug products received for analysis in the Swedish STRIDA project on new psychoactive substances.Identification of MT-45 Metabolites: In Silico Prediction, In Vitro Incubation with Rat Hepatocytes and In Vivo Confirmation.Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace.Chemical synthesis, characterisation and in vitro and in vivo metabolism of the synthetic opioid MT-45 and its newly identified fluorinated analogue 2F-MT-45 with metabolite confirmation in urine samples from known drug users.Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids.Novel Synthetic Opioids: The Pathologist's Point of View
P2860
Q30148688-DEF585A6-D86E-48E9-8135-17EF6474F270Q30379705-B7E3B692-23A2-4EE1-834C-FB3F97F02042Q30491920-21E161F0-13ED-45DF-BC18-A6DDC96F6C42Q33857373-6FE4444A-6D5E-4D14-A8BD-DC23C17D4E96Q34471630-AA0FA003-012F-4B21-ADB1-6D63A5ADF2D8Q34472141-188CBBBF-B39C-40B6-AF24-2E7AC0D521D3Q34481137-94FEF423-8D4C-4AC7-A0C9-02824690E05CQ34512595-0E557215-B2C5-4CC8-895D-F8304D192406Q34521916-5CA860AE-4DEF-41FC-AB38-4A3CF98452F9Q34535066-3DB38A15-708C-4A49-92BC-98F6FE433CC3Q34536442-7D9A150C-F463-40FF-AC8F-9774FE05D88BQ34538105-D4E9DF70-EB20-49C8-AC08-86FE0E06A52EQ34539303-A3CF955C-3F98-46EA-83F5-02495DB2C0A0Q34667835-F20D7B01-E3BB-48FB-AA5F-313A3D233FA6Q38652427-F7072AC9-4E72-4653-B93D-500E365EB973Q38723419-5E5387D3-E7B2-428B-AB99-1B3B795BE85FQ38768825-0D1830AF-9547-4C9D-85E7-B0F7BDA85C7AQ38871683-0AB33AC5-9F11-4C57-9454-2FD78BD62E33Q39604084-7A71ED7A-D95A-4356-BEAB-E1B19F817FF0Q40436637-4693DBF8-BC7C-4DD9-90F5-79E6DFF24DF3Q40620096-5AB8A7DB-0916-413F-BADA-BD863678524CQ44061215-E5873AD0-3356-41B9-8138-A53BB899B5C3Q44336586-51C5F0EF-5F94-4C59-8D95-1CD8386F438DQ44341980-EEECD8AA-0967-4052-A2C4-EB9F051FBF0AQ44344606-B685F809-076F-4CBB-A2D1-B38CA81584C0Q47156013-02D63932-135B-45A9-BB7A-A46207213A1BQ47363908-0A2B3E12-23AD-4512-A5D1-FDE9335A480AQ47895544-9CF8057E-8A70-4279-9C06-8156EF95F9F3Q48296627-7FBFDADE-3134-41A2-96EE-44C546DE8321Q49556857-2F914EBC-0514-4979-97D6-65B8C2C5151CQ53111860-9291328D-0E46-4299-958E-BEC7CF809150Q55416802-C0DF5E67-1649-4921-A882-CC0B7F97C267Q55513198-27B36B22-34D1-480F-B3D7-403BE15FDE93Q58769943-4E31589F-5AB6-40A4-965B-4A19429B2F77
P2860
MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
@ast
MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
@en
MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
@nl
type
label
MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
@ast
MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
@en
MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
@nl
prefLabel
MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
@ast
MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
@en
MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
@nl
P2860
P1433
P1476
MT-45, a new psychoactive substance associated with hearing loss and unconsciousness.
@en
P2093
M Bäckberg
P2860
P304
P356
10.3109/15563650.2014.943908
P407
P577
2014-09-01T00:00:00Z